Towa Pharma is dedicated to researching, developing, producing, and promoting generic drugs.
Reset all filters
01 3Towa Pharmaceutical Sa
02 3A. Menarini Gmbh
03 3ADAMED SRL
04 3Adamed Laboratories Slu
05 3Alter Laboratories Sa
06 3Cinfa Laboratories Sa
07 3DOC GENERICI SRL
08 3EG SPA
09 3Intas Third Party Sales 2005 Sl
10 3KRKA DDNOVO MESTO
11 3Krka Dd Novo Mesto
12 3MENARINI INTERNAT. O.L.S.A
13 3MENARINI INTERNAT. OLSA
14 17Menarini International Operations Luxembourg Sa
15 3Normon Laboratories Sa
16 3Stada Sl Laboratory
17 3Teva Pharma Slu
18 3Umedica Netherlands Bv
Reset all filters
01 68Ranolazine
Reset all filters
01 3Extended Release Tablet
02 12Extended Release Tablets
03 44Extended-Release Tablet
04 3Modified Release Tablet
05 1Ranolazina 375Mg 60 Units Oral Use Rp
06 1Ranolazina 500Mg 60 Units Oral Use Rp
07 1Ranolazina 750Mg 60 Units Oral Use Rp
08 3Tablet
Reset all filters
01 18Italy
02 44Spain
03 3Sweden
04 3Switzerland
Reset all filters
01 3RANEXA
02 3RANOLAZINA DOC GENERIC
03 3RANOLAZINA EG
04 3RANOLAZINA KRKA
05 3RANOZEK
06 23Ranexa
07 3Ranolazina Alter
08 3Ranolazina Cinfa
09 3Ranolazina Intas
10 3Ranolazina Krka
11 3Ranolazina Normon
12 3Ranolazina Stada
13 3Ranolazina Umedica
14 3Ranolazine Teva
15 3Ranolazine Thinks
16 3Ranozek
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Ranolazine Thinks
Dosage Form : Extended-Release Tablet
Dosage Strength : 500MG
Packaging :
Approval Date : 2024-02-06
Application Number : 89168
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Ranolazine Thinks
Dosage Form : Extended-Release Tablet
Dosage Strength : 375MG
Packaging :
Approval Date : 2024-02-06
Application Number : 89167
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Ranolazine Thinks
Dosage Form : Extended-Release Tablet
Dosage Strength : 750MG
Packaging :
Approval Date : 2024-02-06
Application Number : 89169
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info :
Registration Country : Italy
Brand Name : RANOZEK
Dosage Form : Extended Release Tablets
Dosage Strength : 375 mg
Packaging : 60 UNITS 375 MG - ORAL USE (PROLONGED RELEASE)
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : RANOZEK
Dosage Form : Extended Release Tablets
Dosage Strength : 500 mg
Packaging : 60 UNITS 500 MG - ORAL USE (PROLONGED RELEASE)
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : RANOZEK
Dosage Form : Extended Release Tablets
Dosage Strength : 750 mg
Packaging : 60 UNITS 750 MG - ORAL USE (PROLONGED RELEASE)
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : RANOLAZINA DOC GENERIC
Dosage Form : Extended Release Tablets
Dosage Strength : 375 mg
Packaging : 60 UNITS 375 MG - ORAL USE (PROLONGED RELEASE)
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Ranexa
Dosage Form : Ranolazina 375Mg 60 Units Oral Use Rp
Dosage Strength : 60 CPR 375 mg prolonged release
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Ranexa
Dosage Form : Ranolazina 500Mg 60 Units Oral Use Rp
Dosage Strength : 60 CPR 500 mg prolonged release
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Ranexa
Dosage Form : Ranolazina 750Mg 60 Units Oral Use Rp
Dosage Strength : 60 CPR 750 mg prolonged release
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy